Literature DB >> 11164082

Differential effect of low doses of intracerebroventricular corticotropin-releasing factor in forced swimming test.

C García-Lecumberri1, E Ambrosio.   

Abstract

In this work, we studied the effect of low doses of intracerebroventricular corticotropin-releasing factor (CRF) in six sessions of forced swimming test (FST). When CRF (0.01 and 0.1 microg) was administered pre-test, results showed that the 0.1-microg dose significantly increased swimming in SESSION2, SESSION3 and SESSION4, while the 0.01-microg dose proved ineffective. When CRF (0.1 and 0.03 microg) was administered post-test to evaluate retention of swimming response, the dose of 0.1 microg impaired retention, while the dose of 0.03 microg improved it, although these effects only reached significance in SESSION2. In an additional session (SESSION6), testing long-term retention of this swimming response, the 0.1-microg dose significantly impaired retention, whereas the 0.03-microg dose proved ineffective. A high dose of CRF (1 microg) was also included as a control of previous results [García-Lecumberri C, Ambrosio E. Role of corticotropin-releasing factor in forced swimming test. Eur J Pharmacol 1998;343:17-26]. In all the FST sessions, this high dose increased swimming when administered pre-test, while impairing retention when administered post-test. Preliminary data obtained with low doses of CRF suggest that a differential effect on retention of swimming response seems to exist depending on the dose, whereas a high dose of CRF clearly impairs retention. The role of CRF in learning and memory processes in FST is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11164082     DOI: 10.1016/s0091-3057(00)00384-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

1.  Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus.

Authors:  Elizabeth I Flandreau; Kerry J Ressler; Michael J Owens; Charles B Nemeroff
Journal:  Psychoneuroendocrinology       Date:  2011-05-26       Impact factor: 4.905

2.  Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.

Authors:  Lacey L Sahuque; Erika F Kullberg; Andrew J Mcgeehan; Jennifer R Kinder; Megan P Hicks; Mary G Blanton; Patricia H Janak; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2006-03-28       Impact factor: 4.530

3.  Assessing behavioural effects of chronic HPA axis activation using conditional CRH-overexpressing mice.

Authors:  Nina Dedic; Chadi Touma; Cristoph P Romanowski; Marcel Schieven; Claudia Kühne; Martin Ableitner; Ailing Lu; Florian Holsboer; Wolfgang Wurst; Mayumi Kimura; Jan M Deussing
Journal:  Cell Mol Neurobiol       Date:  2011-12-25       Impact factor: 5.046

4.  The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats.

Authors:  Emily M Jutkiewicz; Susan K Wood; Hani Houshyar; Ling-Wei Hsin; Kenner C Rice; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

5.  Effects of high fat or high sucrose diet on behavioral-response to social defeat stress in mice.

Authors:  Deseree M Eudave; McKenna N BeLow; Elizabeth I Flandreau
Journal:  Neurobiol Stress       Date:  2018-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.